Grants

  • 2024-2026

    Australian Functional Genomics Network

    CIA - $60,000
    Location:

    Investigating the pathogenicity of novel SMN1 variants using Zebrafish.

  • 2024-2026

    FightMND

    CIA - $299,791
    Location:

    Generation of inducible and MND-sensitive genetic models for both basic research and drug discovery.

  • 2023-2026

    US Department of Defense Medical Research and Development

    CID - US$1,397,266
    Location:

    Peptide inhibitors targeting sodium channels to treat Amyotrophic Lateral Sclerosis.

  • 2020-2025

    NHMRC Investigator grant (Emerging Leader Fellowship)

    CIA - $614,750
    Location:

    From the identification of drugs against neurodegeneration to a better understanding of synaptic development and function

  • 2022-2025

    FightMND grant

    CIB - $250,000
    Location:

    A high-throughput system to identify ALS risk genes from genome-wide association studies

  • 2019-2024

    NHMRC Project Grant

    CIA - $481,890
    Location:

    Investigating the neuro-developmental role of schizophrenia-associated genes using the zebrafish

  • 2023

    Griffith Equipment Grant

    CIA - $95,000
    Location:

    ZebraLAB Behavioural, Toxicity and Screening platform

  • 2022

    Griffith University Internal Grant

    CIC - $67,488
    Location:

    Replacement cryopreservation system for long term storage of tumorigenic, immortalised and primary cell lines, microorganisms and zebrafish sperm bank.

  • 2019-2021

    Rebecca L. Cooper Medical Research Project Grant

    CIA - $100,000
    Location:

    Unveiling the pathogenic role of the schizophrenia and autism risk-gene NRXN1 in synaptogenesis

  • 2018-2022

    CIHR (Canadian NIH equivalent)

    CIB - CA$627,300
    Location:

    Deciphering the mechanisms of synaptic dysfunction in a genetic model of spinal muscular atrophy.

  • 2017

    Nina Buscombe Award

    Award - $3,000
    Location:

    MND Victoria.

  • 2017

    CASS Award

    Award - $4,000
    Location:

    Innovative genetic approach to recapitulate and study SMA in the zebrafish.

  • 2017-2018

    CureSMA of USA

    CIA - $101,985
    Location:

    Zebrafish models of Spinal Muscular Atrophy optimized for chemical genetics and drug discovery. From proof-of-principle to new insights and treatments. 

  • 2017-2018

    MNDRIA Grant in-aid

    CIA - $99,611.89
    Location:

    New and innovative polygenic approach for understanding and modelling MNDs

  • 2016

    Rebecca L. Cooper Medical Research Equipment Grant

    CIA - $25,000
    Location:

    Using the Zebrafish to fight psychiatric disorders. From proof-of-principle to new insights and treatments.

  • 2014-2017

    NHMRC Project Grant

    CID - $428,835
    Location:

    Seeking a cure for Machado Joseph disease – a prevalent neurodegenerative disease in Aboriginal communities of Arnhem land

  • 2008